Original Research
Accepted on 01 Aug 2024
Cost-effectiveness of pembrolizumab plus chemotherapy vs. chemotherapy as first-line treatment for advanced biliary tract cancer in China and the US
in Drugs Outcomes Research and Policies
Original Research
Accepted on 01 Aug 2024
in Drugs Outcomes Research and Policies
Editorial
Accepted on 01 Aug 2024
in Viral Diversification and Evolution
Original Research
Accepted on 01 Aug 2024
in Migration and Society
Original Research
Accepted on 01 Aug 2024
in Nutritional Epidemiology
Original Research
Accepted on 01 Aug 2024
in Cardiac Electrophysiology
Original Research
Accepted on 01 Aug 2024
in Medical Physics and Imaging
Original Research
Accepted on 01 Aug 2024
in Nutritional Epidemiology
Mini Review
Accepted on 01 Aug 2024
in Perception Science
Review
Accepted on 01 Aug 2024
in Precision Cardiology
Brief Research Report
Accepted on 01 Aug 2024
in Pediatric Rheumatology
Systematic Review
Accepted on 01 Aug 2024
in Movement Disorders
Review
Accepted on 01 Aug 2024
in General Cardiovascular Medicine
Hypothesis and Theory
Accepted on 01 Aug 2024
in Peace and Democracy
Review
Accepted on 01 Aug 2024
in Biosafety and Biosecurity
Original Research
Accepted on 01 Aug 2024
in Brain Imaging Methods
Review
Accepted on 01 Aug 2024
in Integrative and Regenerative Pharmacology